Phase II, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA)-based anti-Cytomegalovirus (CMV) Vaccine (Triplex?), in Adults with Both Human Immunodeficiency Virus (HIV)-1 and CMV Who Are on Potent Combination ART with Conserved Immune Function

Study category: Infectious Diseases

Is this Study for You?

Let's Get Started!



Type of Study



Outpatient CTRC

Principal Investigator
Thomas Campbell,  MD

Thomas Campbell, MD

Study ID

Protocol Number: 21-4360

More information available at NCT05099965

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers